Buchumschlag

Underreporting of molecular targets in surgically treated patients with peritoneal metastasis of gastric cancer

The management of gastric cancer (GC) with peritoneal metastasis (PM) remains a significant clinical challenge. Despite advances in molecular profiling, the underreporting of key molecular markers in patients undergoing surgical treatment for GC with PM is concerning. Signet ring cell (SRC) histolog...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Castagna, Arianna (VerfasserIn) , Ramouz, Ali (VerfasserIn) , Trinidad-Gutiérrez, I. (VerfasserIn) , Brindl, Niall (VerfasserIn) , Brandl, Andreas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 14 October 2025
In: European journal of surgical oncology
Year: 2025, Jahrgang: 51, Heft: 12, Pages: 1-6
ISSN:1532-2157
DOI:10.1016/j.ejso.2025.110502
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ejso.2025.110502
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0748798325009308
Volltext
Verfasserangaben:A. Castagna, A. Ramouz, I. Trinidad-Gutiérrez, N. Brindl, A. Brandl
Beschreibung
Zusammenfassung:The management of gastric cancer (GC) with peritoneal metastasis (PM) remains a significant clinical challenge. Despite advances in molecular profiling, the underreporting of key molecular markers in patients undergoing surgical treatment for GC with PM is concerning. Signet ring cell (SRC) histology is associated with poor prognosis and chemoresistance, while Laurén diffuse subtype is linked to a higher risk for PM. Despite the established role of HER2 in GC progression, its impact on the efficacy of surgical treatment is not clearly defined. The lack of comprehensive reporting on these and recent molecular markers underscores the need for further research. Incorporating molecular diagnostic into clinical practice could improve the personalisation of treatment for GC with PM and overcoming important drug resistance issues, enhancing the effectiveness of current therapy approaches.
Beschreibung:Gesehen am 20.01.2026
Beschreibung:Online Resource
ISSN:1532-2157
DOI:10.1016/j.ejso.2025.110502

Ähnliche Einträge